Pablo Romero-Clavijo

488 total citations
3 papers, 220 citations indexed

About

Pablo Romero-Clavijo is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Pablo Romero-Clavijo has authored 3 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 1 paper in Molecular Biology and 1 paper in Pharmacology. Recurrent topics in Pablo Romero-Clavijo's work include Inflammatory mediators and NSAID effects (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper) and Adenosine and Purinergic Signaling (1 paper). Pablo Romero-Clavijo is often cited by papers focused on Inflammatory mediators and NSAID effects (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper) and Adenosine and Purinergic Signaling (1 paper). Pablo Romero-Clavijo collaborates with scholars based in United Kingdom. Pablo Romero-Clavijo's co-authors include Míriam Molina‐Arcas, Julian Downward, Sareena Rana, Febe van Maldegem, Christopher Moore, Edurne Mugarza, Stuart Horswell, Eleanor Herbert, David C. Hancock and Lian‐Sheng Li and has published in prestigious journals such as Cancer Research, Science Advances and Science Translational Medicine.

In The Last Decade

Pablo Romero-Clavijo

3 papers receiving 218 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pablo Romero-Clavijo United Kingdom	2	149	107	54	44	22	3	220
Antonio Mulero‐Sánchez Netherlands	4	226 1.5×	91 0.9×	37 0.7×	72 1.6×	24 1.1×	6	255
Abhilash Venugopalan United States	8	122 0.8×	124 1.2×	76 1.4×	32 0.7×	25 1.1×	11	224
Niranjan Sudhakar United States	6	175 1.2×	170 1.6×	49 0.9×	72 1.6×	23 1.0×	9	282
T. Trang United States	2	247 1.7×	153 1.4×	76 1.4×	23 0.5×	38 1.7×	2	322
Brian Diskin United States	3	177 1.2×	83 0.8×	27 0.5×	64 1.5×	33 1.5×	5	233
Alex Gaither United States	3	200 1.3×	101 0.9×	72 1.3×	65 1.5×	77 3.5×	6	286
Soma Ghosh United States	8	103 0.7×	106 1.0×	54 1.0×	21 0.5×	32 1.5×	14	192
Bryant Harbourne Canada	5	95 0.6×	81 0.8×	20 0.4×	77 1.8×	20 0.9×	6	190
Iain J. Mulford United States	4	83 0.6×	126 1.2×	65 1.2×	28 0.6×	37 1.7×	5	180
Hongchao Tang China	10	171 1.1×	102 1.0×	49 0.9×	55 1.3×	107 4.9×	25	288

Countries citing papers authored by Pablo Romero-Clavijo

Since Specialization

Citations

This map shows the geographic impact of Pablo Romero-Clavijo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Romero-Clavijo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Romero-Clavijo more than expected).

Fields of papers citing papers by Pablo Romero-Clavijo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Romero-Clavijo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Romero-Clavijo. The network helps show where Pablo Romero-Clavijo may publish in the future.

Co-authorship network of co-authors of Pablo Romero-Clavijo

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Romero-Clavijo. A scholar is included among the top collaborators of Pablo Romero-Clavijo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Romero-Clavijo. Pablo Romero-Clavijo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Mugarza, Edurne, Febe van Maldegem, Jesse Boumelha, et al.. (2022). Therapeutic KRAS ^G12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers. Science Advances. 8(29). eabm8780–eabm8780. 73 indexed citations

2.

Boumelha, Jesse, et al.. (2022). Abstract 1352: In vivo CRISPR screening identifies mediators of immune evasion in KRAS-mutant lung cancer. Cancer Research. 82(12_Supplement). 1352–1352. 1 indexed citations

3.

Molina‐Arcas, Míriam, Christopher Moore, Sareena Rana, et al.. (2019). Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer. Science Translational Medicine. 11(510). 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact